Delivery Order SPE2DB20D1109-SPE2DB25FN43P

Award Date 1/27/25
Potential Completion Date 2/18/25
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPF77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 Firm Fixed Price Delivery Order contract is for the provision of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,085.44 firm fixed-price contract is for the supply of 4567104870 - YONSA 125 MG TABLET 120S, with a completion date of February 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a...
This federal contract award, SPE2DB20D3101|SPE2DB25FQXT0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 4566789448 ! YONSA 125 MG TABLET 120S, with a performance period ending on January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, SPE2DB22D3009|SPE2DB25FAQ03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order contract is for the supply of 4567090480 - YONSA 125 MG TABLET 120S, with a completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,542.74, is a Firm Fixed Price Delivery Order for the supply of YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of January 24, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The Delivery Order contract, valued at $6,586.44, is for the supply of 4564731090 - YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of June 18, 2024 and is a firm fixed price arrangement. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,195.48 firm fixed-price contract is for the supply of YONSA 125 MG TABLET 120S, a specialty pharmaceutical product. The contract has a period of performance through December 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of YONSA 125 MG TABLET 120S, a specialty medication. The $2,195.48 firm fixed-price contract has a performance period through December 10, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $4,390.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of YONSA 125 MG TABLET 120S, a pharmaceutical product, with a completion date of February 21, 2024. The contract is a firm fixed price delivery order and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,271.36, is for the delivery of 4,567,212,894 units of the drug YONSA 125 MG TABLET 120S. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN43P
    Delivery Order

This federal contract award, SPE2DB20D1109|SPE2DB25FN43P, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.36 firm fixed-price delivery order is for the supply of 4567058713 YONSA 125 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of February 18, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/4/25, 12:46 AM